Korro Bio, Inc.

8-K · krro-20260610.htm iXBRL

0001703647 2026-06-10 2026-06-10

  

  
 UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 8-K
  
 CURRENT REPORT
 Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 Date of Report (Date of earliest event report ed): June 10, 2026
  
 Korro Bio, Inc.
 (Exact name of registrant as specified in its charter)
  
  

 Delaware

 001-39062

 47-2324450

 (State or other jurisdiction of
 incorporation)

 (Commission
 File Number)

 (IRS Employer
Identification No.)

 60 First Street , 2 nd floor , Suite 250
 Cambridge , MA

  

 02141

 (Address of principal executive offices)

  

 (Zip Code)

  
 Registrant’s telephone number, including area code: (617) 468-1999
  
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  

 ☐

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  

  

 ☐

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  

  

 ☐

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  

  

 ☐

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  
 Securities registered pursuant to Section 12(b) of the Act:
  

 Title of each class

  

 Trading Symbol(s)

  

 Name of each exchange on which registered

 Common stock, par value $0.001 per share

  

 KRRO

  

 The Nasdaq Capital Market

  
 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 Emerging growth company ☐
 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
  

  

  

 Item 5.07. Submission of Matters to a Vote of Security Holders.
 The following is a summary of the matters voted on at the 2026 annual meeting of stockholders of Korro Bio, Inc., or Korro, held on June 10, 2026, or the Annual Meeting.
 1) Korro’s stockholders elected each of Nessan Bermingham and Rachel Meyers as Class I directors, each for a three-year term ending at the annual meeting of stockholders to be held in 2029 and each until his or her respective successor has been duly elected and qualified or until his or her earlier death, resignation or removal. The results of the stockholders’ vote with respect to the election of the two Class I directors are as follows:

  

 Name

  

 Votes
For

  

 Votes
Withheld

  

 Broker
Non-Votes

 Nessan Bermingham

  

 7,468,003

  

 1,576,660

  

 1,875,955

 Rachel Meyers

  

 7,368,284

  

 1,676,379

  

 1,875,955

  
 2) Korro’s stockholders approved, in a non-binding, advisory vote, the compensation of Korro’s named executive officers. The results of the stockholders’ advisory vote with respect to the compensation of Korro’s named executive officers are as follows:

  

 Votes
For

  

 Votes
Against

  

 Abstain

  

 Broker
Non-Votes

 9,009,739

  

 27,988

  

 6,936

  

 1,875,955

  
 3) Korro’s stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the stockholders’ vote with respect to such ratification are as follows:

  

 Votes
For

  

 Votes
Against

  

 Abstain

  

 Broker
Non-Votes

 10,917,621

  

 2,738

  

 259

  

 0

  

  

  

 SIGNATURES
 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  

  

 KORRO BIO, INC.

  

  

 Date: June 11, 2026

 By:

 /s/ Ram Aiyar

  

  

  

  

  

 Name: Ram Aiyar

  

  

 Title: President and Chief Executive Officer and Interim Chief Financial Officer